Lung cancer risks in women with previous breast cancer.

Evaluation of the adverse effects of breast cancer treatment is becoming increasingly important in light of the earlier detection and prolonged survival of the patients. The beneficial effect of post-surgical radiotherapy has lately been challenged. The Swedish Cancer Registry (SCR) was used to identify approximately 141000 women with breast cancer, diagnosed between 1958 and 1997, followed-up for the occurrence of lung cancer. Standardised incidence ratios and expected number of lung cancers were calculated using incidence rates from the SCR. There were 613 subsequent lung cancers and a statistically significant increased risk of lung cancer was seen >5 years after breast cancer diagnosis, in contrast to a significantly decreased risk the first five years after the breast cancer diagnosis. The latter finding was confined to those >60 years of age when diagnosed with breast cancer. When restricting the analyses to those cases with information on the laterality of breast and lung cancer, an increased risk of a lung cancer on the same side as the breast cancer was seen >10 years after the breast cancer diagnosis. Birth cohorts with a higher smoking prevalence, i.e. 1930-1949, revealed a higher risk of lung cancer, than previous birth cohorts. Women with breast cancer have a significantly increased risk of developing a subsequent lung cancer possibly related to an interaction between radiotherapy and smoking.

[1]  T. Rebbeck Inherited genetic predisposition in breast cancer , 1999, Cancer.

[2]  J. Hendriks,et al.  Histologic multifocality of tis, T1–2 breast carcinomas implications for clinical trials of breast‐conserving surgery , 1985, Cancer.

[3]  Brinton La,et al.  Second cancer following cancer of the breast in Connecticut, 1935-82. , 1985 .

[4]  C. Brekelmans Risk factors and risk reduction of breast and ovarian cancer , 2003, Current opinion in obstetrics & gynecology.

[5]  G. Calais,et al.  Early secondary acute myelogenous leukemia in breast cancer patients after treatment with mitoxantrone, cyclophosphamide, fluorouracil and radiation therapy. , 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

[6]  Mike Clarke,et al.  Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials , 2000 .

[7]  J. R. Landis,et al.  The measurement of observer agreement for categorical data. , 1977, Biometrics.

[8]  J. McLaughlin,et al.  Meta-analyses of p53 tumor suppressor gene alterations and clinicopathological features in resected lung cancers. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[9]  P. Hall,et al.  Radiation-induced breast cancer: long-term follow-up of radiation therapy for benign breast disease. , 1993, Journal of the National Cancer Institute.

[10]  Mike Clarke,et al.  Tamoxifen for early breast cancer: an overview of the randomised trials , 1998, The Lancet.

[11]  P. Ganz Late effects of cancer and its treatment. , 2001, Seminars in oncology nursing.

[12]  S. Rosfors,et al.  Pulmonary function following adjuvant chemotherapy and radiotherapy for breast cancer and the issue of three-dimensional treatment planning. , 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[13]  T. Sellers,et al.  Association of menstrual and reproductive factors with breast cancer risk: Results from the Shanghai breast cancer study , 2000, International journal of cancer.

[14]  I. Russo Cigarette smoking and risk of breast cancer in women , 2002, The Lancet.

[15]  C. la Vecchia,et al.  Alcohol and breast cancer in the Swiss Canton of Vaud. , 1996, European journal of cancer.

[16]  J. Samet,et al.  Radon and lung cancer. , 1989, Journal of the National Cancer Institute.

[17]  H. Liber,et al.  Spectra of X-ray-induced and spontaneous intragenic HPRT mutations in closely related human cells differentially expressing the p53 tumor suppressor gene. , 1997, Radiation research.

[18]  Robert J Cersosimo,et al.  Tamoxifen for Prevention of Breast Cancer , 2003 .

[19]  O. Axelson,et al.  Residential radon exposure and lung cancer in Sweden. , 1994, The New England journal of medicine.

[20]  B. Weber,et al.  Low penetrance genes associated with increased risk for breast cancer. , 2000, European journal of cancer.

[21]  J. Boice,et al.  Preexisting lung disease and lung cancer among nonsmoking women. , 1992, American journal of epidemiology.

[22]  M. McGue When assessing twin concordance, use the probandwise not the pairwise rate. , 1992, Schizophrenia bulletin.

[23]  V. E. Archer,et al.  RADIATION AS THE CAUSE OF LUNG CANCER AMONG URANIUM MINERS. , 1965, The New England journal of medicine.

[24]  Carcinoma of the urinary bladder after treatment with cyclophosphamide for non-Hodgkin's lymphoma. , 1988 .

[25]  Mike Clarke,et al.  Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomised trials involving 31 000 recurrences and 24 000 deaths among 75 000 women , 1992 .

[26]  J. Cerhan,et al.  Tamoxifen therapy for breast cancer and endometrial cancer risk. , 1999, Journal of the National Cancer Institute.

[27]  E. Saxén,et al.  Multiple cancer--an epidemiologic exercise in Finland. , 1985, Journal of the National Cancer Institute.

[28]  F. Berrino,et al.  Patterns of lung cancer risk according to type of cigarette smoked , 1984, International journal of cancer.

[29]  Anthony Howell,et al.  Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Early Breast Cancer Trialists' Collaborative Group. , 1992 .

[30]  M. Levin,et al.  Cancer and tobacco smoking; a preliminary report. , 1950, Journal of the American Medical Association.

[31]  D. Clayton,et al.  Statistical Models in Epidemiology , 1993 .

[32]  E. Buiatti,et al.  Multiple primary cancer incidence in Italy. , 2001, European journal of cancer.

[33]  J. Boice,et al.  Residential radon exposure and lung cancer in Swedish women. , 1992, Health physics.

[34]  M. Rosén,et al.  Cancer Survival in Sweden 1960–1998 Developments Across Four Decades , 2003, Acta oncologica.

[35]  J. Cunningham,et al.  Pattern of p53 gene mutations in breast cancers of women of the midwestern United States. , 1992, Journal of the National Cancer Institute.

[36]  A. Lunde,et al.  The person-number systems of Sweden, Norway, Denmark, and Israel. , 1980, Vital and health statistics. Series 2, Data evaluation and methods research.

[37]  D. Preston,et al.  Cancer incidence in atomic bomb survivors. Part II: Solid tumors, 1958-1987. , 1994, Radiation research.

[38]  C. Rubino,et al.  Increased risk of second cancers following breast cancer: Role of the initial treatment , 2000, Breast Cancer Research and Treatment.

[39]  A. Neugut,et al.  Increased risk of lung cancer after breast cancer radiation therapy in cigarette smokers , 1994, Cancer.

[40]  A. Wambersie,et al.  Introduction to Radiobiology , 1990 .

[41]  P. Newcomb,et al.  Tamoxifen and risk of large bowel cancer in women with breast cancer , 1999, Breast Cancer Research and Treatment.

[42]  R. Doll,et al.  Smoking and Carcinoma of the Lung , 1950, Acta - Unio Internationalis Contra Cancrum.

[43]  M. Levine,et al.  Randomized clinical trial to assess the effectiveness of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer. , 1992, Journal of the National Cancer Institute.

[44]  N. Wolmark,et al.  The incidence of lung carcinoma after surgery for breast carcinoma with and without postoperative radiotherapy , 2003, Cancer.

[45]  L. Pierce,et al.  Definition of the supraclavicular and infraclavicular nodes: implications for three-dimensional CT-based conformal radiation therapy. , 2001, Radiology.

[46]  C. la Vecchia,et al.  Cancer risk in women with previous breast cancer. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

[47]  C. Maack,et al.  Mutagenic activity in nipple aspirates of human breast fluid. , 1980, Cancer research.

[48]  A. Neugut,et al.  Lung carcinoma after radiation therapy in women treated with lumpectomy or mastectomy for primary breast carcinoma , 2003, Cancer.

[49]  A. Levine p53, the Cellular Gatekeeper for Growth and Division , 1997, Cell.

[50]  P. Hall,et al.  Overestimated risk of second primary malignancies in ovarian cancer patients. , 2000, European Journal of Cancer.

[51]  B. Rasmussen,et al.  Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial , 1999, The Lancet.

[52]  R C Brownson,et al.  Gender and histologic type variations in smoking-related risk of lung cancer. , 1992, Epidemiology.

[53]  J. Simon,et al.  A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[54]  Mike Clarke,et al.  Polychemotherapy for early breast cancer: an overview of the randomised trials , 1998, The Lancet.

[55]  M. Pike,et al.  Endogenous hormones as a major factor in human cancer. , 1982, Cancer research.

[56]  C. la Vecchia,et al.  Multiple primary cancers in the Vaud Cancer Registry, Switzerland, 1974-89. , 1993, British Journal of Cancer.

[57]  L. Rutqvist,et al.  Long-term cardiac morbidity and mortality in a randomized trial of pre- and postoperative radiation therapy versus surgery alone in primary breast cancer. , 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[58]  T. Hirayama Non-smoking wives of heavy smokers have a higher risk of lung cancer: a study from Japan. , 1981, British medical journal.

[59]  W. Mackillop,et al.  Mortality from myocardial infarction after adjuvant radiotherapy for breast cancer in the surveillance, epidemiology, and end-results cancer registries. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[60]  A. Luini,et al.  Comparing Radical Mastectomy with Quadrantectomy, Axillary Dissection, and Radiotherapy in Patients with Small Cancers of the Breast , 1981 .

[61]  D. Haber,et al.  Hereditary breast cancer. , 1998, Annual review of medicine.

[62]  C. Grau,et al.  Sensori-neural hearing loss after radiotherapy for nasopharyngeal carcinoma: individualized risk estimation. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[63]  R. Doll,et al.  Mortality from cancer and other causes after radiotherapy for ankylosing spondylitis. , 1965, British medical journal.

[64]  N. Wald,et al.  International Smoking Statistics , 2002 .

[65]  B Mattsson,et al.  Completeness of the Swedish Cancer Register. Non-notified cancer cases recorded on death certificates in 1978. , 1984, Acta radiologica. Oncology.

[66]  C. McArdle,et al.  Pregnancy postponement and childlessness leads to chronic hypervascularity of the breasts and cancer risk , 2002, British Journal of Cancer.

[67]  V. Cokkinides,et al.  Building the evidence base for global tobacco control. , 2000, Bulletin of the World Health Organization.

[68]  H. Bartelink,et al.  Long-term cause-specific mortality of patients treated for Hodgkin's disease. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[69]  V. Pompe‐Kirn,et al.  Second primary cancers in breast cancer patients in Slovenia , 1997, Cancer Causes & Control.

[70]  Y. Nakamura,et al.  Frequent replication errors at microsatellite loci in tumors of patients with multiple primary cancers. , 1994, Cancer Research.

[71]  J. Fraumeni,et al.  Summary: multiple primary cancers in Connecticut, 1935-82. , 1985, National Cancer Institute monograph.

[72]  M. C. Leske,et al.  Alcohol, tobacco and breast cancer – collaborative reanalysis of individual data from 53 epidemiological studies, including 58 515 women with breast cancer and 95 067 women without the disease , 2002, British Journal of Cancer.

[73]  P. Goss,et al.  Aromatase inhibitors in the treatment and prevention of breast cancer. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[74]  F. Edsmyr,et al.  Method for irradiation of parasternal lymph-node metastases. , 1959, Acta radiologica.

[75]  E. Hall,et al.  Radiation-induced second cancers: the impact of 3D-CRT and IMRT. , 2003, International journal of radiation oncology, biology, physics.

[76]  O. Miettinen,et al.  Women's susceptibility to tobacco carcinogens. , 2004, Lung cancer.

[77]  J H Lubin,et al.  Lung cancer risk from residential radon: meta-analysis of eight epidemiologic studies. , 1997, Journal of the National Cancer Institute.

[78]  H. Brenner,et al.  Second primary neoplasms following breast cancer in Saarland, Germany, 1968-1987. , 1993, European journal of cancer.

[79]  C. Harris,et al.  Structure and function of the p53 tumor suppressor gene: clues for rational cancer therapeutic strategies. , 1996, Journal of the National Cancer Institute.

[80]  K. Zedeler,et al.  Postoperative Radiotherapy in High-Risk Premenopausal Women with Breast Cancer Who Receive Adjuvant Chemotherapy , 1997 .

[81]  N. Breslow,et al.  Statistical methods in cancer research. Volume II--The design and analysis of cohort studies. , 1987, IARC scientific publications.

[82]  A. Gazdar,et al.  Early detection of lung cancer: clinical perspectives of recent advances in biology and radiology. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[83]  G. Cooper,et al.  Active and passive smoking and the occurrence of natural menopause. , 1999, Epidemiology.

[84]  A. Hartmann,et al.  The molecular epidemiology of p53 gene mutations in human breast cancer. , 1997, Trends in genetics : TIG.

[85]  C. Begg,et al.  Methodology for evaluating the incidence of second primary cancers with application to smoking-related cancers from the Surveillance, Epidemiology, and End Results (SEER) program. , 1995, American journal of epidemiology.

[86]  Å. Borg,et al.  High Frequency of Multiple Melanomas and Breast and Pancreas Carcinomas in CDKN2A Mutation-Positive Melanoma Families , 2000 .

[87]  Harry Hollema,et al.  Risk and prognosis of endometrial cancer after tamoxifen for breast cancer , 2000, The Lancet.

[88]  Benedick A Fraass,et al.  Potential gains for irradiation of chest wall and regional nodes with intensity modulated radiotherapy. , 2003, International journal of radiation oncology, biology, physics.

[89]  A. Rigby,et al.  Statistical methods in epidemiology. v. Towards an understanding of the kappa coefficient , 2000, Disability and rehabilitation.

[90]  D. Easton,et al.  Risks of cancer in BRCA1-mutation carriers , 1994, The Lancet.

[91]  E. Wynder,et al.  Differences in lung cancer risk between men and women: examination of the evidence. , 1996, Journal of the National Cancer Institute.

[92]  K McPherson,et al.  Breast cancer—epidemiology, risk factors, and genetics , 1994, BMJ : British Medical Journal.

[93]  N. Day,et al.  Lung cancer following Hodgkin′s disease: A case‐control study , 1992, International journal of cancer.

[94]  J. Olsen,et al.  Summary: multiple primary cancers in Denmark, 1943-80. , 1985, National Cancer Institute monograph.

[95]  J. Boice,et al.  Radiotherapy‐Induced Lung Cancer among Women Who Smoke , 1994, Cancer.

[96]  R. Langer,et al.  Influence of Estrogen Plus Progestin on Breast Cancer and Mammography in Healthy Postmenopausal Women: The Women's Health Initiative Randomized Trial , 2003 .

[97]  C K Redmond,et al.  Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. , 1999, Journal of the National Cancer Institute.

[98]  H. Storm,et al.  Multiple primary cancers of the breast, endometrium and ovary. , 1989, European journal of cancer & clinical oncology.

[99]  A. Godwin,et al.  Genetics and ovarian carcinoma. , 1998, Seminars in oncology.

[100]  J. Samet,et al.  Occupational lung cancer. , 1992, Clinics in chest medicine.

[101]  J. Fraumeni,et al.  Lung Cancer after Treatment for Hodgkin's Disease: Focus on Radiation Effects , 2003, Radiation research.

[102]  S. Singletary Rating the Risk Factors for Breast Cancer , 2003, Annals of surgery.

[103]  Norman Wolmark,et al.  Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[104]  R. Miralbell,et al.  Radiation therapy and breast conservation: Cosmetic results and complications , 1992 .

[105]  J. Mehta,et al.  Secondary myelodysplastic syndrome/acute myeloid leukaemia following mitoxantrone-based therapy for breast carcinoma , 2000, British Journal of Cancer.

[106]  E. Strom,et al.  Breast IMRT: new tools leading to new vision. , 2002, International journal of radiation oncology, biology, physics.

[107]  G. Merlo,et al.  Mutations in the p53 gene in primary human breast cancers. , 1991, Cancer research.

[108]  Zhaoming Wang,et al.  Lung cancer and prior tuberculosis infection in Shanghai. , 1987, British Journal of Cancer.

[109]  E. Fearon Human cancer syndromes: clues to the origin and nature of cancer. , 1997, Science.

[110]  P. Shields Tobacco smoking, harm reduction, and biomarkers. , 2002, Journal of the National Cancer Institute.

[111]  E van der Schueren,et al.  Randomized clinical trial to assess the value of breast-conserving therapy in stage I and II breast cancer, EORTC 10801 trial. , 1992, Journal of the National Cancer Institute. Monographs.

[112]  T. Ishimaru,et al.  Lung cancer at autopsy in a‐bomb survivors and controls, Hiroshima and Nagasaki, 1961–1970. I. Autopsy findings and relation to radiation , 1974, Cancer.

[113]  Hui Tian,et al.  BRCA1 physically associates with p53 and stimulates its transcriptional activity , 1998, Oncogene.

[114]  A. Hagenbeek,et al.  Second cancer risk following Hodgkin's disease: a 20-year follow-up study. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[115]  A. Miller,et al.  Are female smokers at higher risk for lung cancer than male smokers? A case-control analysis by histologic type. , 1993, American journal of epidemiology.

[116]  J. Stjernswärd Decreased survival related to irradiation postoperatively in early operable breast cancer. , 1974, Lancet.

[117]  J. Reis-Filho,et al.  Is TTF1 a good immunohistochemical marker to distinguish primary from metastatic lung adenocarcinomas? , 2000, Pathology, research and practice.

[118]  A Ottolenghi,et al.  Radiation pneumonitis after breast cancer irradiation: analysis of the complication probability using the relative seriality model. , 2000, International journal of radiation oncology, biology, physics.

[119]  K. Hemminki,et al.  The nation-wide Swedish family-cancer database--updated structure and familial rates. , 2001, Acta oncologica.

[120]  H. Phillips The role of the p53 tumour suppressor gene in human breast cancer. , 1999, Clinical oncology (Royal College of Radiologists (Great Britain)).

[121]  B Fisher,et al.  Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. , 1985, The New England journal of medicine.

[122]  J. Cerhan,et al.  Adenocarcinoma of the lung is strongly associated with cigarette smoking: further evidence from a prospective study of women. , 2002, American journal of epidemiology.

[123]  C. Land,et al.  Incidence of female breast cancer among atomic bomb survivors, 1950-1985. , 1994, Radiation research.

[124]  A B Nattinger,et al.  Geographic variation in the use of breast-conserving treatment for breast cancer. , 1992, The New England journal of medicine.

[125]  B. Hankey,et al.  Second malignant neoplasms among long-term survivors of ovarian cancer. , 1996, Cancer research.

[126]  T. Hiyama,et al.  Second primary cancers following female breast cancer in Osaka, Japan--a population-based cohort study. , 1987, Japanese journal of clinical oncology.

[127]  M. Pike,et al.  Declining cancer rates in the 1990s. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[128]  Nilanjan Chatterjee,et al.  Estrogen Receptor Breast Cancer Phenotypes in the Surveillance, Epidemiology, and End Results Database , 2002, Breast Cancer Research and Treatment.

[129]  Johan Calltorp,et al.  Health care with equity and cost containment , 1996, The Lancet.

[130]  H. Adami,et al.  Response rate to mailed epidemiologic questionnaires: a population-based randomized trial of variations in design and mailing routines. , 1998, American journal of epidemiology.

[131]  R. Piddington HEALTH AND DISEASES , 1956 .

[132]  J. Luketich,et al.  Sex-specific expression of gastrin-releasing peptide receptor: relationship to smoking history and risk of lung cancer. , 2000, Journal of the National Cancer Institute.

[133]  A. Niemierko,et al.  Risk of pneumonitis in breast cancer patients treated with radiation therapy and combination chemotherapy with paclitaxel. , 2001, Journal of the National Cancer Institute.

[134]  A. Lomax,et al.  Potential role of intensity-modulated photons and protons in the treatment of the breast and regional nodes. , 2003, International journal of radiation oncology, biology, physics.

[135]  J. Kaprio,et al.  Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland. , 2000, The New England journal of medicine.

[136]  B. Trock,et al.  Irradiation-related ischemic heart disease. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[137]  A Ottolenghi,et al.  Long-term cardiac mortality after radiotherapy of breast cancer--application of the relative seriality model. , 1996, The British journal of radiology.

[138]  T. Whelan,et al.  The effects of radiation therapy on quality of life of women with breast carcinoma: results of a randomized trial. Ontario Clinical Oncology Group. , 2000 .

[139]  S. Gapstur,et al.  Selective estrogen receptor modulation and reduction in risk of breast cancer, osteoporosis, and coronary heart disease. , 2001, Journal of the National Cancer Institute.

[140]  M Baum,et al.  Overview of randomized trials of postoperative adjuvant radiotherapy in breast cancer. , 1988, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[141]  A. Neugut,et al.  Lung cancer after radiation therapy for breast cancer , 1993, Cancer.

[142]  Dirk Verellen,et al.  Considerations on treatment efficiency of different conformal radiation therapy techniques for prostate cancer. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[143]  N. Day,et al.  Bladder tumours following chemotherapy and radiotherapy for ovarian cancer: A case—control study , 1995, International journal of cancer.

[144]  I. Lax,et al.  Cardiovascular mortality in a randomized trial of adjuvant radiation therapy versus surgery alone in primary breast cancer. , 1992, International journal of radiation oncology, biology, physics.

[145]  B. Hankey,et al.  Lung cancer after Hodgkin's disease. , 1995, Journal of the National Cancer Institute.

[146]  M. Martel,et al.  Postmastectomy radiotherapy of the chest wall: dosimetric comparison of common techniques. , 2002, International journal of radiation oncology, biology, physics.

[147]  A. Hagenbeek,et al.  Bladder and kidney cancer following cyclophosphamide therapy for non-Hodgkin's lymphoma. , 1995, Journal of the National Cancer Institute.

[148]  A. Jemal,et al.  Lung cancer rates convergence in young men and women in the United States: Analysis by birth cohort and histologic type , 2003, International journal of cancer.

[149]  K J Rothman,et al.  Exploring the relation of alcohol consumption to risk of breast cancer. , 2001, American journal of epidemiology.

[150]  Thomas E Rohan,et al.  Cigarette smoking and the risk of breast cancer in women: a review of the literature. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[151]  J. Samet,et al.  Radon-exposed underground miners and inverse dose-rate (protraction enhancement) effects. , 1995, Health physics.

[152]  R. Hoppe Hodgkin's disease: complications of therapy and excess mortality. , 1997, Annals of oncology : official journal of the European Society for Medical Oncology.

[153]  K. Rothman Epidemiology: An Introduction , 2002 .

[154]  K. Czene,et al.  Environmental and heritable causes of cancer among 9.6 million individuals in the Swedish family‐cancer database , 2002, International journal of cancer.

[155]  Cigarette smoking and risk of breast cancer: a prospective study of 24,329 Norwegian women. , 1990 .

[156]  P. Andersen,et al.  Factors influencing the effect of age on prognosis in breast cancer: population based study , 2000, BMJ : British Medical Journal.

[157]  S. Kvaløy,et al.  Long-term risk of second malignancy after treatment of Hodgkin's disease: the influence of treatment, age and follow-up time. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

[158]  C. Shapiro,et al.  Late effects of adjuvant therapy for breast cancer. , 1994, Journal of the National Cancer Institute. Monographs.

[159]  T. Ouchi,et al.  BRCA1 regulates p53-dependent gene expression. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[160]  M. Stovall,et al.  Second malignant neoplasms among long-term survivors of Hodgkin's disease: a population-based evaluation over 25 years. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[161]  W. Travis,et al.  United States lung carcinoma incidence trends: Declining for most histologic types among males, increasing among females , 1996, Cancer.

[162]  D. Pierce,et al.  Lung cancer in radon-exposed miners and estimation of risk from indoor exposure. , 1995, Journal of the National Cancer Institute.

[163]  D. Wickerham,et al.  Tamoxifen and chemotherapy for axillary node-negative, estrogen receptor-negative breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-23. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[164]  F. Vicini,et al.  Radiation pneumonitis in breast cancer patients treated with conservative surgery and radiation therapy. , 1991, International journal of radiation oncology, biology, physics.

[165]  Toshihide Tsuda,et al.  The TP53 gene, tobacco exposure, and lung cancer , 2003, Human mutation.

[166]  C. Harris,et al.  Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. , 1994, Cancer research.

[167]  R Doll,et al.  Uncovering the effects of smoking: historical perspective , 1998, Statistical methods in medical research.

[168]  D. Schaid,et al.  Novel pattern of p53 gene mutations in an American black cohort with high mortality from breast cancer , 1994, The Lancet.

[169]  R H Hruban,et al.  Association between cigarette smoking and mutation of the p53 gene in squamous-cell carcinoma of the head and neck. , 1995, The New England journal of medicine.

[170]  J. Samet,et al.  Geographic variation in the treatment of localized breast cancer. , 1992, The New England journal of medicine.

[171]  J. Ferlay,et al.  Cancer Incidence in Five Continents , 1970, Union Internationale Contre Le Cancer / International Union against Cancer.

[172]  G. Howe Lung cancer mortality between 1950 and 1987 after exposure to fractionated moderate-dose-rate ionizing radiation in the Canadian fluoroscopy cohort study and a comparison with lung cancer mortality in the Atomic Bomb survivors study. , 1995, Radiation research.

[173]  A. Hagenbeek,et al.  Roles of radiotherapy and smoking in lung cancer following Hodgkin's disease. , 1995, Journal of the National Cancer Institute.

[174]  R. Doll,et al.  Mortality in relation to smoking: 22 years' observations on female British doctors. , 1980, British medical journal.

[175]  H. Adami,et al.  Cigarette smoking, alcohol consumption and risk of breast cancer in young women. , 1988, British Journal of Cancer.

[176]  E. Hall,et al.  Radiobiology for the radiologist , 1973 .

[177]  M. Stovall,et al.  Lung cancer risk and radiation dose among women treated for breast cancer. , 1994, Journal of the National Cancer Institute.

[178]  R. L. Carter,et al.  IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans , 1980, IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans.

[179]  H. Adami,et al.  Breast cancer as a risk factor for other primary malignant diseases. A nationwide cohort study. , 1984, Journal of the National Cancer Institute.

[180]  K. Cummings,et al.  Programs and policies to discourage the use of tobacco products , 2002, Oncogene.

[181]  Julian Peto,et al.  Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer , 1997, The Lancet.

[182]  W P Bennett,et al.  Molecular epidemiology of human cancer risk: gene–environment interactions and p53 mutation spectrum in human lung cancer , 1999, The Journal of pathology.

[183]  W. Willett,et al.  Premenopausal fat intake and risk of breast cancer. , 2003, Journal of the National Cancer Institute.

[184]  J L Kelsey,et al.  Reproductive factors and breast cancer. , 1993, Epidemiologic reviews.

[185]  C. Lewis,et al.  Incidence of multiple primary cancers in a cohort of women diagnosed with breast cancer in southeast England , 2001, British Journal of Cancer.

[186]  E. Negri,et al.  Menopause and colorectal cancer , 2000, British Journal of Cancer.

[187]  I. Lax,et al.  Partial irradiation of the heart. , 2001, Seminars in radiation oncology.

[188]  H. Bartelink,et al.  Postmastectomy radiotherapy: questions for the twenty-first century. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[189]  E. Thurfjell,et al.  Breast cancer survival rates with mammographic screening: similar favorable survival rates for women younger and those older than 50 years. , 1996, Radiology.

[190]  F. Speizer,et al.  Novel germline mutations in the PTENtumour suppressor gene found in women with multiple cancers , 2000, Journal of medical genetics.

[191]  A. E. Saarnak,et al.  An improved technique for breast cancer irradiation including the locoregional lymph nodes. , 2000, International journal of radiation oncology, biology, physics.

[192]  E. A. Graham,et al.  Tobacco smoking as a possible etiologic factor in bronchiogenic carcinoma; a study of 684 proved cases. , 1950, Journal of the American Medical Association.

[193]  R. Monson,et al.  Cancer mortality in women after repeated fluoroscopic examinations of the chest. , 1981, Journal of the National Cancer Institute.

[194]  A. Oshima,et al.  Second Primary Cancers Following Breast Cancer in the Japanese Female Population , 2001, Japanese journal of cancer research : Gann.

[195]  S. Cummings,et al.  Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[196]  Ingvar Andersson,et al.  The Swedish Randomised Mammography Screening Trials: Analysis of Their Effect on the Breast Cancer Related Excess Mortality , 1996, Journal of medical screening.

[197]  D. Neuberg,et al.  The role of radiotherapy in the management of operable locally advanced breast carcinoma , 1997, Cancer.

[198]  P. Pisani Breast cancer: geographic variation and risk factors. , 1992, Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer.

[199]  F. Greco,et al.  Lung cancer in Hodgkin's disease: association with previous radiotherapy. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[200]  J. Freudenheim,et al.  Cigarette smoking, N-acetyltransferase 2 genetic polymorphisms, and breast cancer risk. , 1996, JAMA.

[201]  M. Clarke,et al.  Increasing response rates to postal questionnaires: systematic review , 2002, BMJ : British Medical Journal.